C

Cresco Labs Inc
CNSX:CL

Watchlist Manager
Cresco Labs Inc
CNSX:CL
Watchlist
Price: 0.91 CAD -1.09% Market Closed
Market Cap: 311.4m CAD

Wall Street
Price Targets

CL Price Targets Summary
Cresco Labs Inc

Wall Street analysts forecast CL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CL is 2.62 CAD with a low forecast of 1.77 CAD and a high forecast of 3.41 CAD.

Lowest
Price Target
1.77 CAD
94% Upside
Average
Price Target
2.62 CAD
188% Upside
Highest
Price Target
3.41 CAD
275% Upside
Cresco Labs Inc Competitors:
Price Targets
DPHARMA
Duopharma Biotech Bhd
13% Upside
VRNA
Verona Pharma PLC
25% Upside
SUPN
Supernus Pharmaceuticals Inc
23% Upside
4887
Sawai Group Holdings Co Ltd
43% Upside
4507
Shionogi & Co Ltd
12% Upside
3933
United Laboratories International Holdings Ltd
17% Upside
AJANTPHARM
Ajanta Pharma Ltd
18% Upside

Revenue
Forecast

Revenue Estimate
Cresco Labs Inc

The compound annual growth rate of Cresco Labs Inc's revenue for the next 3 years is 0%.

N/A
Past Growth
0%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Cresco Labs Inc

The compound annual growth rate of Cresco Labs Inc's operating income for the next 2 years is -7%.

N/A
Past Growth
-7%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Cresco Labs Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CL's stock price target?
Price Target
2.62 CAD

According to Wall Street analysts, the average 1-year price target for CL is 2.62 CAD with a low forecast of 1.77 CAD and a high forecast of 3.41 CAD.

What is Cresco Labs Inc's Revenue forecast?
Projected CAGR
0%

The compound annual growth rate of Cresco Labs Inc's revenue for the next 3 years is 0%.

What is Cresco Labs Inc's Operating Income forecast?
Projected CAGR
-7%

The compound annual growth rate of Cresco Labs Inc's operating income for the next 2 years is -7%.

Back to Top